RE: Rns morning afternoon or Friday17 Sep 2020 23:54
Sensetalka - Firstly, there is more than 1 RNS expected in the next few weeks. But if you're referring to the FDA approval, my complete guess work (or wish), based on what has happened with other Pharma's, is that this should exceed £2/2.50. This would make GDR a £100/130m market cap company. Still the lowest market cap out of most of the pharmas with Covid test solutions. Obviously, and news from Beckman, India etc will put another rocket up its ass, figuratively speaking.
My target here for the next 6 months is closer to £5 though, with Covid highly likely to get worse, if not much worse, in the winter and the need for more and faster tests being critical to not shutting down countries /economies as we did in the Spring